Area of research
Oncology · Immunology
Research interest
Research interests include Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, SARS-CoV-2 and COVID-19 Research, and CAR-T cell therapy research.
Multiple early factors anticipate post-acute COVID-19 sequelae
CD4+ T cell and M2 macrophage infiltration predict dedifferentiated liposarcoma patient outcomes
A randomised, single-blind, placebo-controlled, dose-finding safety and tolerability study of the anti-CD3 monoclonal antibody otelixizumab in new-onset type 1 diabetes